Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,894 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The aldo-keto reductase superfamily homepage.
Hyndman D, Bauman DR, Heredia VV, Penning TM. Hyndman D, et al. Among authors: penning tm. Chem Biol Interact. 2003 Feb 1;143-144:621-31. doi: 10.1016/s0009-2797(02)00193-x. Chem Biol Interact. 2003. PMID: 12604248
Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action.
Steckelbroeck S, Jin Y, Gopishetty S, Oyesanmi B, Penning TM. Steckelbroeck S, et al. Among authors: penning tm. J Biol Chem. 2004 Mar 12;279(11):10784-95. doi: 10.1074/jbc.M313308200. Epub 2003 Dec 12. J Biol Chem. 2004. PMID: 14672942 Free article.
The roles of aldo-keto reductases in steroid hormone action.
Bauman DR, Steckelbroeck S, Penning TM. Bauman DR, et al. Among authors: penning tm. Drug News Perspect. 2004 Nov;17(9):563-78. doi: 10.1358/dnp.2004.17.9.872570. Drug News Perspect. 2004. PMID: 15645014 Review.
Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
Bauman DR, Steckelbroeck S, Williams MV, Peehl DM, Penning TM. Bauman DR, et al. Among authors: penning tm. Mol Endocrinol. 2006 Feb;20(2):444-58. doi: 10.1210/me.2005-0287. Epub 2005 Sep 22. Mol Endocrinol. 2006. PMID: 16179381
1,894 results